Clorox Company (The) (NYSE:CLX) EVP James E. Foster sold 9,861 shares of Clorox Company (The) stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the transaction, the executive vice president now owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of Clorox Company (CLX) traded up 0.37% during trading on Friday, hitting $137.48. The stock had a trading volume of 367,640 shares. The stock’s 50-day moving average price is $134.08 and its 200 day moving average price is $134.60. The stock has a market cap of $17.74 billion, a price-to-earnings ratio of 25.77 and a beta of 0.40. Clorox Company has a one year low of $111.24 and a one year high of $141.76.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.30 EPS. On average, equities analysts forecast that Clorox Company will post $5.67 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Insider Selling: Clorox Company (The) (CLX) EVP Sells 9,861 Shares of Stock” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright & trademark law. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/25/insider-selling-clorox-company-the-clx-evp-sells-9861-shares-of-stock.html.

A number of equities analysts have commented on CLX shares. Deutsche Bank AG restated a “hold” rating and issued a $137.00 target price (up from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. BMO Capital Markets restated a “buy” rating and issued a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, BidaskClub downgraded Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research report on Monday, July 24th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $129.05.

Institutional investors have recently added to or reduced their stakes in the company. American Beacon Advisors Inc. bought a new position in Clorox Company (The) during the first quarter worth about $104,000. Parkside Financial Bank & Trust boosted its position in Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after buying an additional 29 shares in the last quarter. Valley National Advisers Inc. boosted its position in Clorox Company (The) by 0.6% in the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after buying an additional 5 shares in the last quarter. Blue Chip Partners Inc. boosted its position in Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares in the last quarter. Finally, Sun Life Financial INC boosted its position in Clorox Company (The) by 10,344.4% in the second quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after buying an additional 931 shares in the last quarter. Institutional investors and hedge funds own 69.83% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.